Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-10 08:20:57 - browse：233

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Today, we explore the future of obesity drugs and how they’re named, we chat with CRISPR pioneers about what it’s like to see the technology approved for human use, and more.

The need-to-know this morning:
• Bayer said it prematurely stopped a Phase 3 study in stroke prevention after independent monitors concluded its experimental blood-thinning medicine, called asundexian, showed inferior efficacy compared to a standard treatment. The asundexian study setback is a significant blow to Bayer’s effort to revamp its drug-development pipeline, analysts said.
• Carmot Therapeutics filed paperwork Friday for an initial public offering of undisclosed size. The Berkeley, Calif.-based company is developing drugs that target GLP-1 and GIP to treat diabetes and obesity, similar to Novo Nordisk’s Ozempic/Wegovy and Eli Lilly’s Mounjaro/Zepbound.
• Bristol Myers Squibb and 2Seventy Bio said the FDA will not complete an on-time review of its application seeking to expand the use of Abecma, their CAR-T therapy for multiple myeloma. Instead, the FDA will convene an advisory panel meeting — date to be determined — to examine survival data from an Abecma clinical trial.
• The U.K. and the pharmaceutical industry have reached a deal on a five-year plan outlining how the health system pays for drugs, as the country tries to keep a lid on its medicines spending while simultaneously building up its life sciences industry. STAT’s Andrew Joseph has more here.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Why palliative psychiatry is worth discussing

WSS

How AI can help patients find reliable information about doctors

FDA clears Verve to begin U.S. study of gene

STAT Readout: Friday, Oct. 20 biotech updates

Antivenom research: Lessons from HIV applied in search for universal antidote

UnitedHealth, Optum discontinue NaviHealth name

Study on Amgen’s bispecific immunotherapy produces positive data

knowledge

Wikipedia

entertainment

How to save PrEP access — and even expand it

The problems with dementia villages

Wildfire smoke exposes gaps in outdoor worker protections

STAT Readout Newsletter: Biotech news today

Trump demands the U.S. pay no more for drugs than other countries … again

In utero gene editing: an explainer

Apple is now the first public company to be valued at $3 trillion

6 phony surgeries that take placebo to the extreme

Jerome Adams on the need for new antivirals for Covid

New documents shed light on MD Anderson Cancer Institute feud

knowledge

Why palliative psychiatry is worth discussing

He's a Nobel laureate. Critics say he was misleading on Covid

Why palliative psychiatry is worth discussing

UnitedHealth, Optum discontinue NaviHealth name

Obesity drugs seen as possible treatment for liver disease MASH

FDA clears Verve to begin U.S. study of gene

leisure time

hotspot

focus

Wikipedia